Ondansetron Solution
Product Images NDC 16714-671

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 16714-671). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (4 mg/5 mL (50 mL Bottle))

Label for Ondansetron Oral Solution USP 4 mg per 5 mL, 50 mL bottle, manufactured for NorthStar Rx LLC. The label includes dosage information, storage instructions, and manufacturing details by Aurobindo Pharma Limited. The product is an oral solution with ondansetron hydrochloride as the active ingredient.*

FDA Label Image

Fig2 (Ondansetron Fig2)

Ondansetron Oral Solution, USP 4 mg/5 mL in a 50 mL bottle label by NorthStar Rx LLC. The label includes NDC 16714-671-02, dosage instructions, storage conditions, and manufacturing details citing NorthStar Rx LLC in Memphis, TN, and Aurobindo Pharma Limited in India. Packaging features dosage and handling instructions along with barcodes and regulatory information.*

FDA Label Image

Chemical Structure (Ondansetron Str)

Chemical structure of ondansetron hydrochloride dihydrate. The diagram depicts the molecular arrangement of atoms in the compound used in Ondansetron oral solution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.